Image source: Getty Images.
What: Investors in Indian drugmaker Dr. Reddy’s Labs (NYSE: RDY) are having a rough day. The company’s stock has plunged by more than 18% as of 2:50 p.m. EST after the company reported results from the first quarter of fiscal year 2017.